TURNSTONE BIOLOGICS CORP (TSBX) Stock Balance Sheet
NASDAQ:TSBX - Nasdaq - US90042W1009 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash Equivalents | 24.13M | 17.80M | 34.73M | 123.38M | |||
| Marketable Securities | 21.15M | 76.98M | 47.33M | 37.64M | |||
| Receivables | 0.00 | 194.00K | 8.73M | 6.71M | |||
| Other Current Assets | 5.86M | 7.58M | 7.21M | 9.61M | |||
| Total Current Assets | 51.14M | 102.55M | 98.00M | 177.34M | |||
| Non-Current Assets | |||||||
| PPE Net | 6.47M | 9.12M | 14.36M | 9.37M | |||
| Other Non-Current Assets | 873.00K | 1.14M | 2.58M | 536.00K | |||
| Total Non-Current Assets | 7.34M | 10.26M | 16.94M | 9.90M | |||
| TOTAL ASSETS | 58.48M | 112.81M | 114.94M | 187.24M | |||
| LIABILITIES | |||||||
| Current Liabilities | |||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 13.08M | 11.93M | 16.23M | 20.83M | |||
| Accounts Payable | 560.00K | 36.00K | 3.44M | 28.00K | |||
| Other Current Liabilities | N/A | 0.00 | 15.16M | 34.12M | |||
| Total Current Liabilities | 13.64M | 11.97M | 34.83M | 54.98M | |||
| Non-Current Liabilities | |||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.20M | 2.18M | 9.63M | 42.37M | |||
| Total Non-Current Liabilities | 1.20M | 2.18M | 9.63M | 42.37M | |||
| TOTAL LIABILITIES | 14.84M | 14.15M | 44.46M | 97.34M | |||
| SHAREHOLDERS' EQUITY | |||||||
| Retained Earnings | -234.72M | -176.76M | -121.56M | -90.72M | |||
| Additional Paid In Capital | 278.54M | 275.52M | 20.50M | 9.12M | |||
| Common Shares | 23.00K | 23.00K | 171.95M | 171.76M | |||
| Other Shareholders' Equity | -196.00K | -119.00K | -413.00K | -245.00K | |||
| Shares Outstanding | 23.13M | 147.89M | 22.19M | 22.19M | |||
| Tangible Book Value per Share | 1.89 | 0.67 | -4.57 | -3.69 | |||
| Total Shareholders' Equity | 43.64M | 98.67M | 70.48M | 89.90M | |||
| TOTAL LIABILITIES AND EQUITY | 58.48M | 112.81M | 114.94M | 187.24M | |||
| Statistics | |||||||
| Current Ratio | 3.75 | 8.57 | 2.81 | 3.23 | |||
| Return On Assets (ROA) | -127.24% | -48.96% | -26.99% | 1.86% | |||
| Return On Equity (ROE) | -170.52% | -55.99% | -44.02% | 3.87% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 19.71% | |||
All data in USD , ROIC based on taxRate of 0.21